ImmunAbs

ImmunAbs is a clinical-stage biotech company established by experts in global standard antibody therapeutics development. ImmunAbs has 20 years of experience in developing best-in-class monoclonal antibodies using technologies such as phage display and single B cell cloning to obtain humanized antibodies from immunized animal species. Our lead pipeline is currently in a phase 1 clinical trial in the US and will move forward to a phase 2a clinical trial in 2024.


URL: http://www.immunabs.com/

Location: Korea

Previous
Previous

LISCure Biosciences

Next
Next

VIZZIO.AI